Quick Answer
Oscar Health, Inc. reported Cash And Cash Equivalents At Carrying Value of $2.77 billion for the year ending 2025.
- Oscar Health, Inc. showed an increase of +81.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Oscar Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $491.71 million | Q2 2020: $988.53 million | Q3 2020: $337.41 million | Q1 2021: $2.32 billion | Q2 2021: $1.67 billion | Q3 2021: $1.08 billion | Q1 2022: $2.07 billion | Q2 2022: $2.36 billion | Q3 2022: $2.11 billion | Q1 2023: $2.11 billion | Q2 2023: $2.32 billion | Q3 2023: $1.40 billion | Q1 2024: $2.23 billion | Q2 2024: $2.27 billion | Q3 2024: $1.21 billion | Q1 2025: $2.24 billion | Q2 2025: $2.60 billion | Q3 2025: $2.15 billion.
- Over the full 7 years of available data (2019 to 2025), Oscar Health, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 724.1%.
- Historical annual values: Fiscal year 2025: $2.77 billion | Fiscal year 2024: $1.53 billion | Fiscal year 2023: $1.87 billion | Fiscal year 2022: $1.56 billion | Fiscal year 2021: $1.10 billion | Fiscal year 2020: $826.33 million | Fiscal year 2019: $336.64 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: